ESS

Clinical trials for ESS explained in plain language.

Never miss a new study

Get alerted when new ESS trials appear

Sign up with your email to follow new studies for ESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug shows promise for Hard-to-Treat uterine sarcomas

Disease control Recruiting now

This study tests a drug called elacestrant in people with advanced uterine sarcomas that have estrogen receptors. The drug works by blocking estrogen, which may help shrink or slow the cancer. About 30 adults with certain types of uterine sarcoma will take the drug to see if it i…

Matched conditions: ESS

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated May 26, 2026 08:08 UTC

ESS

Get alerted when new ESS trials appear

New drug shows promise for Hard-to-Treat uterine sarcomas